A GLOBAL PRESENCE
TO TAKE CARE OF YOU
OMEGA-3 EPA & DHA
EVERYONE NEEDS IT
OMEGA-3 AND THE LONG-TERM
BENEFIT FOR YOUR HEALTH
KD Pharma and kd-pür® have long been synonymous with Omega-3 fish oil quality and purity. Our ability to provide customer solutions is what sets us apart. Our purity, oil concentration and batch-to-batch consistency have been the result of constant innovation and a desire for continual improvement.
This, combined with a plant capacity that can meet your volume needs, ranging from concentrates to Active Pharmaceutical Ingredient (API), has made KD Pharma the Omega-3 Solution Experts for over two decades.
The KD Pharma team is getting ready for Vitafoods 2017. Come visit us at Stand H59 to find out more about our new product KD Smart™ and our Analytical Testing Services!KEEP READING
Study Demonstrates Pre and Postnatal Benefits of Adequate Omega-3 Fatty Acid Levels in Pregnant Women
SALT LAKE CITY, Jan. 28, 2016 /PRNewswire/ -- A study published in the European Journal of Obstetrics & Gynecology and Reproductive Biology titled "Effects of Omega-3 Fatty Acids in Prevention of Early Preterm Delivery: A Systematic Review and Meta-Analysis of Randomized Studies," found omega-3 supplement consumption was associated with a 58 percent decrease in the likelihood of early preterm birth (babies born before 34 weeks) and a 17 percent decrease in any preterm delivery (babies born before 37 weeks). In addition, the data shows a longer gestation period and higher average infant birth weight.
"This research underscores much of what we already knew about the importance of EPA and DHA for infant development, and it builds on research that strongly suggests these omega-3s are a key to health throughout life," said Dr. Harry Rice, vice president of regulatory and scientific affairs for the Global Organization for EPA and DHA Omega-3s (GOED). "Experts know that carrying a baby full-term strongly increases the likelihood of a healthy baby post-delivery, which means omega-3 consumption is crucial for pregnant women."KEEP READING
SALT LAKE CITY, March 18, 2016 /PRNewswire/ -- According to the World Health Organization, depression is a major cause of disease burden worldwide, affecting an estimated 350 million people. In 2014, the National Institutes of Mental Health estimated that 15.7 million adults aged 18 or older in the United States had at least one major depressive episode in the previous year.
A new meta-analysis published in Translational Psychiatry supports the link between intake of EPA and DHA omega-3 fatty acids, nutrients found in certain varieties of fatty fish, and reduction in the symptoms of major depressive disorder (MDD). The meta-analysis, which included the results of 13 studies and 1,233 total participants, showed a benefit for EPA and DHA supplementation that is comparable to effects reported in similar meta-analyses of antidepressant use. The positive effect was greater in studies supplementing with higher doses of EPA, and there was also a positive benefit seen in patients already taking antidepressants.KEEP READING